Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Revenue: 2009-2024

Historic Revenue for Myriad Genetics (MYGN) over the last 16 years, with Dec 2024 value amounting to $837.6 million.

  • Myriad Genetics' Revenue fell 3.56% to $205.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $825.3 million, marking a year-over-year increase of 0.21%. This contributed to the annual value of $837.6 million for FY2024, which is 11.21% up from last year.
  • Per Myriad Genetics' latest filing, its Revenue stood at $837.6 million for FY2024, which was up 11.21% from $753.2 million recorded in FY2023.
  • Over the past 5 years, Myriad Genetics' Revenue peaked at $837.6 million during FY2024, and registered a low of $557.1 million during FY2020.
  • For the 3-year period, Myriad Genetics' Revenue averaged around $756.4 million, with its median value being $753.2 million (2023).
  • Per our database at Business Quant, Myriad Genetics' Revenue fell by 24.97% in 2020 and then increased by 23.96% in 2021.
  • Yearly analysis of 5 years shows Myriad Genetics' Revenue stood at $638.6 million in 2020, then reached $557.1 million in 2020, then rose by 23.96% to $690.6 million in 2021, then decreased by 1.77% to $678.4 million in 2022, then climbed by 11.03% to $753.2 million in 2023, then rose by 11.21% to $837.6 million in 2024.